StonvexLoading…
StonvexCore line items from SRI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $861.26M | $908.29M | $975.82M | $899.92M |
Operating Income | $-38.61M | $-381.00K | $12.84M | $2.94M |
Net Income | $-102.83M | $-16.52M | $-5.18M | $-14.06M |
EPS (Diluted) | $-3.70 | $-0.60 | $-0.19 | $-0.52 |
Total Assets | $551.19M | $621.56M | $679.90M | $652.11M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $66.25M | $71.83M | $40.84M | $54.80M |
Free Cash Flow OCF − CapEx | $12.17M | $23.45M | $-33.55M | $-20.43M |
Shares Outstanding | 28.02M | 27.70M | 27.55M | 27.34M |